Project Grant K01MH137689
Award Date
6/1/25
Completion Date
5/31/30
Dollars Obligated
$185K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award of $475,388 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program will fund research to characterize the transcriptional and neuro-immune consequences of loss of the high-confidence bipolar disorder risk gene KDM5B. The research aims to investigate the impact of stress on behavior and gene transcription in wild-type and KDM5B heterozygous mice, as well as characterize the neuro-immune responses in KDM5B+/-...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $500,500.00 to St. Jude Children's Research Hospital Inc. to study the LRRC57 gene and its role in neurotrophic growth factor signaling, synaptic function, and behavior related to bipolar disorder. The award period runs from August 1, 2024 to July 31, 2026. The project aims to elucidate the biochemical functions of LRRC57, identify its...
The National Institute of Mental Health (NIMH) awarded a 5-year, $857,216 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to study the neurodevelopmental trajectories leading to early symptoms of Attention Deficit Hyperactivity Disorder (ADHD) and disruptive behaviors in socioeconomically disadvantaged, racially and ethnically diverse children. The key objectives of this project are to: 1)...
The National Institute of Mental Health (NIMH) awarded a $1,401,862 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to the University of California, Berkeley. The 5-year grant, which commenced on September 21, 2024, will support research to investigate the role of the orbitofrontal cortex (OFC) in inhibiting habitual responses in the striatum to enable goal-directed decision-making. The researchers will use a novel behavioral task and advanced neural recording...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is funding a $267,310 research project conducted by Trustees of Boston University, doing business as Boston University Medical Campus. The project aims to compare the spatial distribution, kinetics, and synaptic physiology of dendritic inhibition on pyramidal cells in the anterior cingulate cortex (ACC) and lateral prefrontal cortex (LPFC) of rhesus macaques....
This federal Project Grant award of $606,029.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research at the University of Massachusetts Medical School (UMass Medical) to investigate the neurocircuitry underlying motivated reward-seeking behavior in response to stress. The key goals of the research are to: 1) Determine if a subpopulation of GABAergic neurons in the medial habenulo-interpeduncular (MHB-IPN) axis...
The National Institute of Mental Health (NIMH) awarded a $206,875 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Research Foundation For Mental Hygiene, Inc. (RFMH) to investigate the impact of GRIN2B/GLUN2B disruption on dopaminergic function and related behaviors. The project aims to use a conditional Cre/Lox strategy in mice to assess the effects of diminished GLUN2B signaling on dopaminergic neuron firing, dopamine release, and downstream behaviors such as impulsivity and...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $233,250 to The Washington University to conduct research on the relationship between neuroinflammation and anhedonia, a symptom of mental health disorders. The project aims to utilize UK Biobank and Adolescent Brain Cognitive Development datasets, along with the innovative Diffusion Basis Spectrum Imaging technique, to investigate the...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to identify biomarkers in the cerebellar-cortical circuitry that can predict treatment response to antipsychotic medication in patients with early psychosis. The $519,558 award, which runs from June 2025 to April 2030, will enable the Feinstein Institutes for Medical Research to validate the identified predictive biomarker in a larger sample...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $714,615 to New York University School of Medicine to conduct research on dissecting the role of non-coding repeats in the genetics of psychiatric disorders like schizophrenia and bipolar disorder. The key objectives are to: Fine map regulatory features of a repeat expansion within the CACNA1C gene, which has been strongly associated with...